Nonsteroidal Mineralocorticoid Receptor Antagonist in Type 2 Diabetes–Associated Chronic Kidney Disease

Source: Navigating the Latest Options for the Treatment of CKD in T2D
Download Slideset
A leading expert provides an overview of the cardiorenal benefits of finerenone in patients with type 2 diabetes and chronic kidney disease.
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Format: Microsoft PowerPoint (.ppt)
File Size: 2.54 MB
Released: July 7, 2022

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by independent educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
Bayer HealthCare Pharmaceuticals Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings